首页> 外文期刊>Current hypertension reports. >Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.
【24h】

Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

机译:肾交感神经消融:高血压治疗的新领域。

获取原文
获取原文并翻译 | 示例
           

摘要

The sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, as elevated sympathetic nerve activity initiates and sustains the elevation of blood pressure. Increased sympathetic outflow to the heart, resulting in increased cardiac output and neurally mediated vasoconstriction of peripheral blood vessels, is an obvious example of a neural pathophysiologic pathway leading to elevated blood pressure. The consequences of increased sympathetic outflow to the kidneys, perhaps most important in this context, are sodium and water retention, increased renin release, and alterations of renal blood flow-effects that contribute substantially to both acute and long-term blood pressure elevations. Accordingly, renal sympathetic nerve ablation appears to be a logical therapeutic approach for the treatment of hypertension. Recent reports on a novel catheter-based renal nerve ablation procedure reviewed in this article are promising.
机译:交感神经系统在循环和代谢控制中起着重要作用,并且由于交感神经活动的增强引发并维持了血压的升高,因此已经明确地被确定为高血压发展的主要因素。交感神经向心脏的流出增加,导致心输出量增加和周围血管的神经介导的血管收缩,是导致血压升高的神经病理生理途径的明显例子。交感神经向肾脏的流出可能是在这种情况下最重要的结果,其结果是钠和水retention留,肾素释放增加以及肾脏血流影响的改变,这对急性和长期血压升高均起重要作用。因此,肾交感神经消融似乎是治疗高血压的合乎逻辑的治疗方法。本文中对基于导管的新型肾神经消融术的最新报道很有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号